Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer

Ashish M. Kamat, Antonia Vlahou, John A. Taylor, Mdliss A. Hudson, Beate Pesch, Molly A. Ingersoll, Tilmann Todenhöfer, Bas van Rhijn, Wassim Kassouf, H. Barton Grossman, Thomas Behrens, Ashish Chandra, Peter J. Goebell, Juan Palou, Marta Sanchez-Carbayo, Bernd J. Schmitz-Dräger